Bioxytran Inc (BIXT)
0.117
-0.01
(-6.25%)
USD |
OTCM |
May 31, 16:00
Bioxytran Net Income (Quarterly): -0.8003M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.8003M |
| December 31, 2023 | -1.046M |
| September 30, 2023 | -1.001M |
| June 30, 2023 | -1.411M |
| March 31, 2023 | -0.7851M |
| December 31, 2022 | -0.8057M |
| September 30, 2022 | -0.1236M |
| June 30, 2022 | -0.6223M |
| March 31, 2022 | -0.9123M |
| December 31, 2021 | -1.038M |
| September 30, 2021 | -0.4752M |
| June 30, 2021 | -0.8967M |
| March 31, 2021 | -1.622M |
| December 31, 2020 | -0.8095M |
| September 30, 2020 | -0.202M |
| June 30, 2020 | -0.9286M |
| March 31, 2020 | -0.5405M |
| December 31, 2019 | -0.6627M |
| September 30, 2019 | -0.8741M |
| June 30, 2019 | -0.1303M |
| March 31, 2019 | -0.1914M |
| December 31, 2018 | -0.2479M |
| September 30, 2018 | -0.0475M |
| June 30, 2018 | -0.0003M |
| March 31, 2018 | -0.0007M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.0864M |
| September 30, 2017 | 0.0489M |
| June 30, 2017 | -0.2604M |
| March 31, 2017 | -0.0646M |
| December 31, 2016 | 0.1353M |
| September 30, 2016 | -0.214M |
| June 30, 2016 | -0.163M |
| March 31, 2016 | -0.455M |
| December 31, 2015 | -0.115M |
| September 30, 2015 | -0.0301M |
| June 30, 2015 | -1.916M |
| March 31, 2015 | -0.0391M |
| December 31, 2014 | -0.2353M |
| September 30, 2014 | -1.116M |
| June 30, 2014 | -0.0582M |
| March 31, 2014 | 0.0628M |
| December 31, 2013 | 0.1117M |
| September 30, 2013 | -0.2772M |
| June 30, 2013 | -0.639M |
| March 31, 2013 | -0.974M |
| December 31, 2012 | -0.6752M |
| September 30, 2012 | -0.4873M |
| June 30, 2012 | -0.666M |
| March 31, 2012 | -0.4669M |
| December 31, 2011 | -2.554M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-1.622M
Minimum
Mar 2021
-0.1236M
Maximum
Sep 2022
-0.7844M
Average
-0.8076M
Median
Net Income (Quarterly) Benchmarks
| Shuttle Pharmaceuticals Holdings Inc | -1.731M |
| NovaBay Pharmaceuticals Inc | -3.214M |
| Palatin Technologies Inc | -8.436M |
| iBio Inc | -3.172M |
| Theriva Biologics Inc | -5.165M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.7858M |
| EPS Diluted (Quarterly) | -0.0049 |
| Enterprise Value | 20.74M |
| Earnings Yield | -29.84% |
| Normalized Earnings Yield | -986.32 |